Aprea Therapeutics, Inc. (APRE)

Cash & Short-Term Investments

$41.23M

Quarterly · Period ending: · USD

APRE logo

APRE Cash & Short-Term Investments

Latest reported$14.60M
APRE FY Cash & Short-Term Investments ($24.40M → $14.60M)
High-resolution chart · PNG

APRE cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
14,599,347
22,849,885
21,606,820
28,786,647
53,076,052
89,017,686
130,088,869
65,675,931
24,401,488
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.